FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Isosol Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Increasing depth of anesthesia with Isoflurane,USP may increase hypotension and respiratory depression. The electroencephalographic pattern associated with deep anesthesia is characterized by burst suppression, spiking, and isoelectric periods.4
Since levels of anesthesia may be altered easily and rapidly, only vaporizers producing predictable percentage concentrations of isoflurane should be used. (See DOSAGE AND ADMINISTRATION).
The action of nondepolarizing relaxants is augmented by isoflurane. Less than the usual amounts of these drugs should be used. If the usual amounts of nondepolarizing relaxants are given, the time for recovery from myoneural blockade will be longer in the presence of isoflurane than in the presence of other commonly used anesthetics.
Not for use in horses intended for food.
Keep out of reach of children.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Isoflurane, USP is used for induction and maintenance of general anesthesia in horses and dogs.
History
There is currently no drug history available for this drug.
Other Information
Isoflurane, USP is a nonflammable, nonexplosive general inhalation anesthetic agent. Its chemical name is l-chloro-2,2,2-trifluoroethyl difluoromethyl ether, and its structural formula is:
Each mL contains 99.9% isoflurane.
Some physical constants are:
Molecular weight |
|
184.5 |
Boiling point at 760 mm Hg |
|
48.5° C (uncorr.) |
Refractive index |
|
1.2990-1.3005 |
Specific gravity 25°/25° C |
|
1.496 |
Vapor pressure in mm Hg** |
20° C |
238 |
|
25° C |
295 |
|
30° C |
367 |
|
35° C |
450 |
**Equation for vapor pressure calculation:
log10Pvap= A + B/T
where: A = 8.056
B = -1664.58
T = °C + 273.16 (Kelvin)
Partition coefficients at 37° C: |
|
|
|
Water/gas |
0.61 |
|
Blood/gas |
1.43 |
|
Oil/gas |
90.8 |
Partition coefficients at 25° C - rubber and plastic |
|||
|
Conductive rubber/gas |
62.0 |
|
|
Butyl rubber/gas |
75.0 |
|
|
Polyvinyl chloride/gas |
110.0 |
|
|
Polyethylene/gas |
~2.0 |
|
|
Polyurethane/gas |
~1.4 |
|
|
Polyolefin/gas |
~1.1 |
|
|
Butyl acetate/gas |
~2.5 |
|
Purity by gas chromatography |
>99.9% |
||
Lower limit of flammability in oxygen or nitrous oxide at 9 joules/sec. and 23° C |
None |
||
Lower limit of flammability in oxygen or nitrous oxide at 900 joules/sec. and 23° C |
Greater than useful concentration in anesthesia. |
MAC (Minimum Alveolar Concentration) is 1.31% in horses1 and 1.28% in dogs.6
Isoflurane is a clear, colorless, stable liquid containing no additives or chemical stabilizers. Isoflurane has a mildly pungent, musty, ethereal odor. Samples stored in indirect sunlight in clear, colorless glass for five years, as well as samples directly exposed for 30 hours to a 2 amp, 115 volt, 60 cycle long wave U.V. light were unchanged in composition as determined by gas chromatography. Isoflurane in one normal sodium methoxide-methanol solution, a strong base, for over six months consumed essentially no alkali, indicative of strong base stability. Isoflurane does not decompose in the presence of soda lime (at normal operating temperatures), and does not attack aluminum, tin, brass, iron or copper.
Sources
Isosol Manufacturers
-
Vedco, Inc.
Isosol | Vedco, Inc.
CautionOperating rooms should be provided with adequate ventilation to prevent the accumulation of anesthetic vapors.
PremedicationPremedication: A premedication regimen, which may be employed depending upon the patient
Inspired Concentration
status, to avert excitement during induction, might include an anticholinergic, a tranquilizer, a
muscle relaxant, and a short-acting barbiturate.Inspired Concentration: The delivered concentration of Isoflurane, USP should be known.
Induction
Isoflurane may be vaporized using a flow-through vaporizer specifically calibrated for
isoflurane. Vaporizers delivering a saturated vapor which is then diluted (e.g. Vernitrol®
vaporizer) also may be used. The delivered concentration from such a vaporizer may be
calculated using the formula:
% Isoflurane = 100 PvFv
FT (PA – Pv)
where: PA = Pressure of atmosphere
PV = Vapor pressure of isoflurane
FV = Flow of gas through vaporizer (mL/min)
FT = Total gas flow (mL/min)
Isoflurane contains no stabilizer. Nothing in the drug product alters calibration or operation of
these vaporizers.Horses: Inspired concentrations of 3.0% to 5.0% isoflurane alone with oxygen following a
barbiturate anesthetic induction are usually employed to induce surgical anesthesia in the horse.
Dogs: Inspired concentrations of 2.0% to 2.5% isoflurane alone with oxygen following a
barbiturate anesthetic induction are usually employed to induce surgical anesthesia in the dog.
These concentrations can be expected to produce surgical anesthesia in 5 to 10 minutes.
Maintenance: The concentration of vapor necessary to maintain anesthesia is much less than
that required to induce it.
Horses: Surgical levels of anesthesia in the horse may be sustained with a 1.5% to 1.8%
concentration of isoflurane in oxygen.
Dogs: Surgical levels of anesthesia in the dog may be sustained with a 1.5% to 1.8%
concentration of isoflurane in oxygen.
The level of blood pressure during maintenance is an inverse function of isoflurane concentration
in the absence of other complicating problems. Excessive decreases, unless related to
hypovolemia, may be due to depth of anesthesia and in such instances may be corrected by
lightening the level of anesthesia. Recovery from isoflurane anesthesia is typically uneventful.2
Login To Your Free Account